首页 > SCI期刊 > Asia-pacific Journal Of Clinical Oncology
评价信息:
影响因子:2.012
《亚太临床肿瘤学杂志》(Asia-pacific Journal Of Clinical Oncology)是一本国际期刊。该刊由WILEY出版商创刊于2005年,刊期6 issues/year。该刊已被国际重要权威数据库SCI、SCIE收录。
Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.
《亚太临床肿瘤学杂志》是一本多学科的肿瘤学杂志,旨在成为一个促进合作和交流信息的论坛,以了解亚太地区不同国家在癌症治疗和护理方面的情况。该杂志非常适合发表与种族、文化、经济和其他人群差异有关的癌症行为、管理和结果多样性的出版物。除了原创文章外,该杂志还发表评论、社论、致编辑的信和简短通讯。病例报告通常不考虑发表,只有编辑认为具有非凡肿瘤学价值的优秀论文才可能被考虑审阅。该杂志鼓励临床研究,尤其是前瞻性设计的临床试验。
《Asia-pacific Journal Of Clinical Oncology》(亚太临床肿瘤学杂志)编辑部通讯方式为Asia-Pac. J. Clin. Oncol.。如果您需要协助投稿或润稿服务,您可以咨询我们的客服老师。我们专注于期刊投稿服务十年,熟悉发表政策,可为您提供一对一投稿指导,避免您在投稿时频繁碰壁,节省您的宝贵时间,有效提升发表机率,确保SCI检索(检索不了全额退款)。我们视信誉为生命,多方面确保文章安全保密,在任何情况下都不会泄露您的个人信息或稿件内容。
Gold OA文章占比 | 研究类文章占比 | 文章自引率 |
-- | -- | -- |
开源占比 | 出版国人文章占比 | OA被引用占比 |
0.11... | 0.08 | 0.07... |
名词解释:JCR分区在学术期刊评价、科研成果展示、科研方向引导以及学术交流与合作等方面都具有重要的价值。通过对期刊影响因子的精确计算和细致划分,JCR分区能够清晰地反映出不同期刊在同一学科领域内的相对位置,从而帮助科研人员准确识别出高质量的学术期刊。
历年引文指标和发文量
2019-2021年国家/地区发文量统计
国家/地区 | 数量 |
Australia | 1151 |
CHINA MAINLAND | 147 |
USA | 106 |
Japan | 61 |
England | 54 |
South Korea | 38 |
Canada | 36 |
Singapore | 32 |
France | 28 |
Taiwan | 28 |
2019-2021年机构发文量统计
机构 | 数量 |
UNIVERSITY OF SYDNEY | 234 |
UNIVERSITY OF NEWCASTLE | 175 |
PETER MACCALLUM CANCER CENTER | 144 |
UNIVERSITY OF MELBOURNE | 109 |
UNIVERSITY OF NEW SOUTH WALES SYDNEY | 103 |
HUNTER MEDICAL RESEARCH INSTITUTE | 102 |
MONASH UNIVERSITY | 91 |
UNIVERSITY OF QUEENSLAND | 88 |
UNIVERSITY OF WESTERN AUSTRALIA | 77 |
CALVARY MATER NEWCASTLE HOSPITAL | 76 |
2019-2021年文章引用数据
文章引用名称 | 引用次数 |
Biomarkers and therapeutic advances in g... | 26 |
Metastatic triple negative breast cancer... | 17 |
Strain-specific probiotic (microbial cel... | 13 |
PD-L1 expression associated with worse s... | 13 |
Identifying the most prevalent unmet nee... | 13 |
The impacts of pretreatment circulating ... | 12 |
Cancer multidisciplinary team meetings i... | 11 |
Exosomal tetraspanins as regulators of c... | 10 |
Primary thromboprophylaxis (PTP) in ambu... | 10 |
Clinical response to apatinib monotherap... | 9 |
2019-2021年文章被引用数据
被引用期刊名称 | 数量 |
SUPPORT CARE CANCER | 24 |
ASIA-PAC J CLIN ONCO | 23 |
FRONT ONCOL | 23 |
BMC CANCER | 18 |
FUTURE ONCOL | 18 |
BMJ OPEN | 15 |
CANCERS | 15 |
COCHRANE DB SYST REV | 15 |
ONCOL LETT | 15 |
MEDICINE | 14 |
2019-2021年引用数据
引用期刊名称 | 数量 |
J CLIN ONCOL | 209 |
ANN ONCOL | 84 |
LANCET ONCOL | 80 |
INT J RADIAT ONCOL | 75 |
NEW ENGL J MED | 73 |
CANCER-AM CANCER SOC | 72 |
EUR J CANCER | 52 |
EUR UROL | 43 |
BRIT J CANCER | 41 |
LANCET | 37 |
若用户需要出版服务,请联系出版商:Asia-Pac. J. Clin. Oncol.。